IAN Stock Overview
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
iAnthus Capital Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.055 |
| 52 Week Low | CA$0.01 |
| Beta | 0.64 |
| 11 Month Change | -50.00% |
| 3 Month Change | -60.00% |
| 1 Year Change | -66.67% |
| 33 Year Change | -96.43% |
| 5 Year Change | -99.48% |
| Change since IPO | -99.31% |
Recent News & Updates
Improved Revenues Required Before iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Jump Looks Justified
Sep 10
Benign Growth For iAnthus Capital Holdings, Inc. (CSE:IAN) Underpins Stock's 40% Plummet
Jul 26iAnthus Capital Holdings, Inc. (CSE:IAN) Stock Catapults 50% Though Its Price And Business Still Lag The Industry
May 05Recent updates
Improved Revenues Required Before iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Jump Looks Justified
Sep 10Benign Growth For iAnthus Capital Holdings, Inc. (CSE:IAN) Underpins Stock's 40% Plummet
Jul 26iAnthus Capital Holdings, Inc. (CSE:IAN) Stock Catapults 50% Though Its Price And Business Still Lag The Industry
May 05iAnthus Capital Holdings, Inc. (CSE:IAN) Stocks Pounded By 29% But Not Lagging Industry On Growth Or Pricing
Feb 29iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 17Is iAnthus Capital Holdings (CSE:IAN) Using Debt Sensibly?
Feb 28Is iAnthus Capital Holdings (CSE:IAN) A Risky Investment?
Aug 25Shareholder Returns
| IAN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -33.3% | 0.6% | -0.3% |
| 1Y | -66.7% | -3.8% | 21.1% |
Return vs Industry: IAN underperformed the Canadian Pharmaceuticals industry which returned -3.8% over the past year.
Return vs Market: IAN underperformed the Canadian Market which returned 21.1% over the past year.
Price Volatility
| IAN volatility | |
|---|---|
| IAN Average Weekly Movement | 54.1% |
| Pharmaceuticals Industry Average Movement | 10.1% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.0% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: IAN's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: IAN's weekly volatility has increased from 42% to 54% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 760 | Richie Proud | www.ianthus.com |
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products.
iAnthus Capital Holdings, Inc. Fundamentals Summary
| IAN fundamental statistics | |
|---|---|
| Market cap | CA$66.27m |
| Earnings (TTM) | -CA$84.39m |
| Revenue (TTM) | CA$229.28m |
0.3x
P/S Ratio-0.8x
P/E RatioIs IAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IAN income statement (TTM) | |
|---|---|
| Revenue | US$167.53m |
| Cost of Revenue | US$100.37m |
| Gross Profit | US$67.16m |
| Other Expenses | US$128.82m |
| Earnings | -US$61.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0093 |
| Gross Margin | 40.09% |
| Net Profit Margin | -36.81% |
| Debt/Equity Ratio | -209.8% |
How did IAN perform over the long term?
See historical performance and comparison